IMMUNIC, INC. - Common Stock (IMUX)

Historical Holders from Q2 2019 to Q3 2025

Symbol
IMUX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
120M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
42.7M
Holdings value
$37.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
61
Number of buys
24
Number of sells
-19
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IMMUNIC, INC. - Common Stock (IMUX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 9.99% +233% $8.53M $6.62M 12M +347% JANUS HENDERSON GROUP PLC 28 Nov 2025
Alyeska Investment Group, L.P. 9.35% -5.5% $9.92M $1.56M 11.3M +18.6% Alyeska Investment Group, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 9.99% $8.83M 10.6M Nantahala Capital Management, LLC 30 Jun 2025
683 Capital Management, LLC 9.9% $8.83M 10.6M 683 CAPITAL MANAGEMENT, LLC 02 Aug 2025
Adage Capital Management, L.P. 9.99% +422% $8.7M $7.54M 10.5M +649% Adage Capital Management, L.P. 30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 9.99% $8.12M 9.79M BVF PARTNERS L P/IL 30 Jun 2025
Aberdeen Group plc 8.6% $6.84M 8.24M Aberdeen Group plc 30 Jun 2025
Avidity Partners Management LP 4.8% -18.3% $4.14M -$808K 4.7M -16.3% Avidity Partners Management LP 30 Sep 2025
VANGUARD GROUP INC 4.35% $4.47M 3.92M The Vanguard Group 31 Dec 2024
Soleus Private Equity Fund III, L.P. 1.6% $1.39M 1.58M Soleus Capital Management, L.P. 30 Sep 2025
RTW INVESTMENTS, LP 1.1% $1.17M 1.03M RTW Investments, LP 31 Mar 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $328K -$49.8K 372K -13.2% Armistice Capital, LLC 30 Sep 2025

Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 42.7M $37.6M -$6.01M $0.88 61
2025 Q2 50.2M $35M +$6.04M $0.70 55
2025 Q1 40.5M $44.1M -$10.9M $1.09 63
2024 Q4 51.1M $51.1M -$5.07M $1.00 65
2024 Q3 56M $92.4M +$4.08M $1.65 61
2024 Q2 55.8M $62.1M -$1.86M $1.11 57
2024 Q1 57.4M $75.7M +$55.6M $1.32 60
2023 Q4 15.1M $22.7M -$4.87M $1.50 49
2023 Q3 18.4M $27M -$3.55M $1.47 53
2023 Q2 20.2M $50.7M -$8.73M $2.51 62
2023 Q1 24.8M $36.9M +$1.13M $1.49 57
2022 Q4 24.4M $34M +$5.45M $1.40 59
2022 Q3 17.4M $55.1M -$3.09M $3.16 62
2022 Q2 18.3M $63.4M -$15.2M $3.47 65
2022 Q1 17.6M $199M +$44.4M $11.30 78
2021 Q4 13.7M $131M +$7.6M $9.57 66
2021 Q3 12.9M $114M +$30.2M $8.85 66
2021 Q2 9.43M $116M -$1.4M $12.26 56
2021 Q1 9.3M $148M -$6.17M $15.94 60
2020 Q4 9.73M $149M +$11.6M $15.29 66
2020 Q3 8.55M $159M +$86.1M $18.57 64
2020 Q2 4.21M $51M +$24.9M $12.12 47
2020 Q1 2.16M $13M +$104K $6.01 15
2019 Q4 2.14M $20.7M +$6.19M $9.70 14
2019 Q3 1.5M $15M -$480K $10.00 18
2019 Q2 1.54M $17.6M +$17.6M $11.46 20